Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) to treat cardiometabolic diseases, today announced the commercial launch of AspyreRx, the first cognitive behavioral therapy (CBT) app to receive U.S Food and Drug Administration (FDA) authorization as a Class II device to treat adults with type 2 diabetes (T2D).
FINEOS, the leading modern enterprise core software for the life, accident and health industry, has forged a partnership with Osara Health, a digital health platform founded by oncologists, to enhance the care experience for individuals dealing with cancer.
BIOQuébec and BioFlorida, preeminent life sciences associations from Québec and Florida, are proud to announce the signing of a Memorandum of Understanding (MOU).
Parker Health and OutCare Health proudly announce a groundbreaking research and care delivery partnership with a mission to redefine healthcare models for LGBTQ+ health, particularly within underserved and minority populations.
Akili, Inc., the leading digital medicine company behind EndeavorOTC™, today released results from a new study examining the ways in which ADHD impacts the U.S. workforce.
Tilak Healthcare, a pioneer and leading player in the field of ophthalmological digital health, has raised €10 million in a funding round led by Elaia and Cap Horn.
Discovery Health, the leading health insurance administrator providing administration and managed care services to more than 3.8 million individuals, has partnered with Amwell® (NYSE: AMWL), a global leader in hybrid health care enablement, to introduce the first-ever digital therapeutic benefits funded by a health insurer in South Africa.
Clinical Data Interchange Standards Consortium (CDISC) and Digital Medicine Society (DiMe) are proud to announce a groundbreaking partnership aimed at enhancing the standardization of digital health technologies (DHTs) data.
The healthcare industry generates approximately 30% of the world's data volume. Unfortunately, this data is often coded using a varied number of coding systems which makes it difficult to consolidate, standardize and deduplicate data for continuity of care, analytics, and AI applications
FEops, a leader in personalized predictive planning for structural heart interventions, announced today its partnership with ConcertAI's TeraRecon, for the commercialization of FEops HEARTguide’s for Left Atrial Appendage (LAA) occlusion workflow, with a strong focus on the US market.